A recent study published in Progress in Neuropsychopharmacology & Biological Psychiatry suggests that cannabidiol (commonly ...

The MAVERIC-2 trial will evaluate the impact of CardiolRx™ in recurrent pericarditis patients following the cessation of ...

An expert explained how a patient’s own T cells can be extracted, manufactured and infused back into the body as a treatment ...

Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

However, this did not hold true if plants were the protein source. Interestingly, they found a high-protein plant diet may ...

Company remains on track in late-stage, potentially registrational trials of nemvaleukin alfa, with data readouts expected in late Q1/early Q2 ...

Treatment with IV secukinumab led to rapid improvements in the signs and symptoms of PsA, which were maintained through 52 weeks.

presented to its investors. Tourmaline Bio, Inc. is a clinical-stage biotechnology company focused on developing ...

T-cell therapy is a revolutionary immunotherapy approach in which T cells are genetically modified to express a receptor that ...

In a recent study, researchers at the University of California, San Diego, have provided new insights into the central role ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Enrolling Patients in Second Dosing CohortInterim Data from Atopic Dermatitis Trial ...